Freemelt (FREEM) Investor update summary
Event summary combining transcript, slides, and related documents.
Investor update summary
9 Sep, 2026Strategic update and business expansion
Strategy expanded to include manufacturing qualified parts for end customers, moving beyond 3D printer sales and addressing demand for serial production and resilient supply chains.
Two business areas established: equipment/production system sales (e.g., MedTech) and qualified part manufacturing for sectors like fusion and defense.
Leveraging E-PBF technology, expertise in extreme materials, and established customer relationships to support both in-house and outsourced manufacturing needs.
New business area launched with a major order from Fusion for Energy, linked to the ITER project, highlighting demand for qualified manufacturing in advanced sectors.
Company aims to emulate advanced manufacturing models seen in China, targeting critical applications and manufacturing resilience in Europe.
Market opportunity and financial ambitions
Addressable market opportunity expanded to SEK 450–560 billion for manufacturing and assembly, compared to SEK 20–30 billion for equipment sales.
Recent order involves producing 31,000 tungsten tiles and monoblocks over 22 months, valued at SEK 55–84 million.
Approach is equity-light, leveraging partnerships, scalable external capacity, and asset financing tied to contracts to minimize capital investment.
Financial targets reaffirmed: SEK 1 billion annual order intake by 2030 and EBITDA positive by 2028.
Expecting more than half of revenues to come from recurring sources such as services, aftermarket, and long-term customer relationships.
Operational outlook and risk assessment
Key KPIs include order intake, order book health, and business mix.
Technology proven with 45 systems sold and over 40 qualification projects completed in two years.
Main risk identified as geopolitical competition, with urgency for Europe to establish manufacturing resilience.
Vision to become an industrial platform for extreme materials and critical applications in Europe, supporting customers from technology adoption to industrial deployment.
Organic growth prioritized, with selective acquisitions considered to complement the industrial platform.
Latest events from Freemelt
- Order intake rose and cash flow turned positive despite lower sales, driven by new strategic deals.FREEM
Q2 2026 - Record sales, fusion breakthroughs, and China entry drive growth in AM and medtech.FREEM
Investor Update - Scaling up with 162% revenue growth, new funding, and global expansion in MedTech, defense, and fusion.FREEM
Investor update - Q1 net sales rose 116% YoY, with strong margins and key sector collaborations advancing.FREEM
Q1 2026 - Sales up 172% to SEK 54.5m, installed base up 40%, and strong growth in key sectors.FREEM
Q4 2025 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days - Q2 saw high activity, new orders, and strategic partnerships despite a wider loss.FREEM
Q2 2024 - First industrial eMELT sale, OEM order, and machine sales growth amid ongoing losses.FREEM
Q3 2024 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 2024